Precision Trials: Navigating the Complexity of Immuno-Oncology
Immuno-oncology (I-O) therapies represent one of the boldest frontiers in cancer treatment, but running I-O trials is inherently complex. These […]
November 8, 2025
The Speed Advantage: How to Cut Site Activation Time Without Sacrificing Quality
In clinical development, time lost is progress delayed. One of the largest bottlenecks in getting a trial underway is the
More Than a Protocol: Designing Patient-Centric Trials for Rare Diseases
For sponsors working in the rare disease space, the challenge is immense. With small patient populations, geographically scattered individuals, and
The Data-Driven Future: Why AI is the Agility Engine for Modern CROs
For too long, clinical research has been a game of chance—relying on historical data, slow manual processes, and educated guesses.